Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue

Breast Cancer Research and Treatment

Volumn 40, Issue 2, 1996, Pages 171-178

  Yu, He ^a,b   Diamandis, Eleftherios P ^a,b   Levesque, Michael ^a,b   Giai, Maurizia ^c   Roagna, Riccardo ^c   Ponzone, Riccardo ^c   Sismondi, Piero ^c   Monne, Maria ^d   Croce, Carlo M ^d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TURIN   (Italy)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Benign breast disease; Breast cancer; Fibroadenomas; Prostate specific antigen; Steroid hormone receptors; Steroid hormones

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; STEROID HORMONE; STEROID RECEPTOR; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER STAGING; CLINICAL ARTICLE; FIBROADENOMA; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029789295     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806212     Document Type: Article

References (33)

1. Yu H, Diamandis EP, Sutherland DJA: Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 27: 75-79, 1994
2. Diamandis EP, Yu H, Sutherland DJA: Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 33: 301-310, 1994
3. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque M et al.: Prostate specific antigen is a new favourable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110, 1995
4. Oesterling JE: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923, 1991
5. Armbruster DA: Prostate specific antigen: biochemistry, analytical methods and clinical application. Clin Chem 39: 181-195, 1993
6. Henttu P, Liao S, Vinko P: Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 130: 766-772, 1992
7. Kamoshida S, Tsutsumi Y: Extra prostatic localization of prostatic acid phosphatase and prostate-specific antigen: distribution of cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum Pathol 21: 1108-1111, 1990
8. Iwakiri J, Granbois K, Wehner N, Graves HCB, Stamey T: An analysis of urinary prostate specific antigen before and after radical prostatectomy. Evidence for secretion of prostate specific antigen by the periurethral gland. J Urol 149: 783-786, 1993
9. van Krieken JH: Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry. Am J Surg Pathol 17: 410-414, 1993
10. Wernert N, Albrech M, Sesterhenn J et al.: The 'Female Prostate': Location morphology, immunohistochemical characteristics and significance. Eur Urol 22: 64-69, 1992
11. Clements J. Mukhtar A: Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 78: 1536-1539, 1994
12. Yu H, Diamandis EP, Levesque M, Sismondi P, Zola P, katsaros D: Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary. J Clin Lab Analysis 8: 251-253, 1994
13. Yu H, Diamandis EP, Levesque M, Asa SL, Monne M, Croce CM: Expression of the prostate specific antigen gene by a primary ovarian carcinoma. Cancer Res 55: 1603-1606, 1995
14. Bilgrami S, Singh NT, Shafi N, Ciesielski T: Raised prostate-specific antigen in adenocarcinoma of lung. Lancer 344: 1371-1372, 1994
15. Yu H, Diamandis EP, Zarghami N, Grass L: Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 32: 291-300, 1994
16. Yu H, Diamandis EP: Prostate specific antigen in milk of lactating women. Clin Chem 41: 54-58, 1995
17. Diamandis EP, Yu H, Lopez-Otin: Prostate specific antigen - a new constituent of breast cyst fluid. Breast Cancer Res Treat (in press)
18. Yu H, Diamandis EP, Monne M, Croce CM: Oral contraceptive-induced expression of prostate specific antigen in the female breast. J Biol Chem 270: 6615-6618, 1995
19. Monne M, Croce CM, Yu H, Diamandis EP: Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res 54: 6344-6347, 1994
20. Yu H, Diamandis EP: Ultrasensitive time-resolved immunofluorometric assay of prostate specific antigen in serum and preliminary clinical studies. Clin Chem 39: 2108-2114, 1993
21. Riegman PHJ, Klaasen P, van der Korput JAGM, Romijn JC, Trapman J: Molecular cloning and characterization of novel prostate antigen cDNA's. Biochem Biophys Res Commun 155: 181-188, 1988
22. Lilja H: A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 76: 1899-1903, 1985
23. Yu H, Diamandis EP: Prostate specific antigen immunoreactivity in amniotic fluid. Clin Chem 41: 204-210, 1995
24. Killian CS, Corral DA, Kawinski E, Constantine RII: Mitrogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-b and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun 192: 940-947, 1993
25. Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A: Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: Correlation with serum prostate-specific antigen. Thrombosis Res 64: 309-320, 1991
26. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenbeld RG: Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 75: 1046-1054, 1992
27. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H: Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. Cancer Res 54: 5474-5478, 1994
28. Pathologists - Consensus statement. Relative risk of developing invasive breast carcinoma based on pathologic examination of benign breast tissue. Arch Pathol Lab Med 110: 171-173, 1986
29. Highes LE, Mansel RE, Webster DTT: The epidemiology of benign breast disease and assessment of cancer risk. In: Benign disorders and diseases of the breast: concepts and clinical management. London, England: Bailliere Tindall 27-39, 1989
30. McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gierell D et al: Histologic types of benign breast disease and the risk for breast cancer. Cancer 69: 1408-1414, 1992
31. Levi F, Randimbison L, Te V, LaVecchia C: Incidence of breast cancer in women with fibroadenoma. Int J Cancer 57: 681-683, 1994
32. Dupont WD, Page DL, Parl FF, Vnencak-Tones CL, Plummer WD Jr, Rados MS, Schuyler PA: Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 331: 1259-1264, 1994
33. Nandi S, Guzman RC, Yang J: Hormones and mammary carcinogenesis in mice, rats and humans: A unifying hypothesis. Proc Natl Acad Sci USA 92: 3650-3657, 1995